Genmab A (GMAB) Current Deferred Revenue (2023 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Genmab A (GMAB) has disclosed Current Deferred Revenue for 1 consecutive years, with $3.0 million as the latest value for Q4 2024.

• For the quarter ending Q4 2024, Current Deferred Revenue changed N/A year-over-year to $3.0 million, compared with a TTM value of $3.0 million through Dec 2024, changed N/A, and an annual FY2024 reading of $3.0 million, changed N/A over the prior year.
• Current Deferred Revenue was $3.0 million for Q4 2024 at Genmab A.
• Across five years, Current Deferred Revenue topped out at $3.0 million in Q4 2024 and bottomed at $3.0 million in Q4 2024.

Peer Comparison